Pionix-M

Pionix-M

pioglitazone + metformin

Manufacturer:

Kalbe Farma
Concise Prescribing Info
Contents
Per 15 mg/500 mg tab Pioglitazone 15 mg, metformin HCl 500 mg. Per 15 mg/850 mg tab Pioglitazone 15 mg, metformin HCl 850 mg
Indications/Uses
As an adjunct to diet & exercise to improve glycemic control in adult w/ type 2 DM not adequately controlled on metformin HCl or pioglitazone alone, or treated already w/ the combination of pioglitazone & metformin HCl, as separate tab.
Dosage/Direction for Use
Patient inadequately controlled on Metformin monotherapy 15 mg/500 mg or 15 mg/850 mg once or twice daily. Patient who initially responded to pioglitazone monotherapy & require additional glycemic control 15 mg/500 mg twice daily or 15 mg/850 mg once daily. Patient switching from combination therapy of pioglitazone plus metformin as separate tab 15 mg/500 mg or 15 mg/850 mg based on the dose of pioglitazone or metformin already being taken.
Administration
Should be taken with food.
Contraindications
Cardiac failure or history of cardiac failure (NYHA stages I-IV); acute or chronic disease which may cause tissue hypoxia eg, cardiac or resp failure, recent MI, shock, hepatic impairment, acute alcohol intoxication, renal failure or dysfunction (CrCl <60 mL/min). Pregnancy & lactation.
Special Precautions
CHF, edema, renal & hepatic impairment, alcohol intake, surgery.
Adverse Reactions
Diarrhea, nausea, edema, headache, dizziness, wt increase, anemia, resp & urinary tract infection.
MIMS Class
ATC Classification
A10BD05 - metformin and pioglitazone ; Belongs to the class of combinations of oral blood glucose lowering drugs. Used in the treatment of diabetes.
Presentation/Packing
Form
Pionix-M 15 mg/500 mg tab
Packing/Price
30's (Rp225,000/pak)
Form
Pionix-M 15 mg/850 mg tab
Packing/Price
30's (Rp231,000/pak)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in